Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 82
Number Thumbnail Title Author Date Votes Views
82 Prestige Biopharma and Syntekabio Join Forces on AI-Driven Drug Development
김** | 2026.11.10 | Votes 0 | Views 277
김** 2026.11.10 0 277
81 Prestige Biopharma Unveils Subcutaneous Injection Platform at AAPS in the U.S., Explores Licensing Opportunities
김** | 2026.10.26 | Votes 0 | Views 748
김** 2026.10.26 0 748
80 Prestige Biopharma to Present Phase 1 Clinical Data for Pancreatic Cancer Drug Candidate PBP1510 at ESMO 2026
김** | 2026.10.23 | Votes 0 | Views 976
김** 2026.10.23 0 976
79 Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships
김** | 2026.10.07 | Votes 0 | Views 1190
김** 2026.10.07 0 1190
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 1258
김** 2026.10.01 0 1258
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 1156
김** 2026.09.30 0 1156
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 1584
김** 2026.09.28 0 1584
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 1537
김** 2026.09.18 0 1537
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 1259
김** 2026.09.17 0 1259
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1788
김** 2026.09.09 0 1788

Read Prestige news >>